| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |